INFECTIVE COLITIS

Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial
Giles Major, Lucy Bradshaw, Nafisa Boota, Kirsty Sprange, Mathew Diggle, Alan Montgomery, Aida Jawhari, Robin C Spiller

Gut Jul 2019, 68 (7) 1224-1231; DOI: 10.1136/gutjnl-2018-316794
Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin
Zhen He, Raad Z Gharaibeh, Rachel C Newsome, Jllian L Pope, Michael W Dougherty, Sarah Tomkovich, Benoit Pons, Gladys Mirey, Julien Vignard, David R Hendrixson, Christian Jobin

Gut Feb 2019, 68 (2) 289-300; DOI: 10.1136/gutjnl-2018-317200
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, Victoria L McCune, Melissa Baxter, Gemma L Marsden, David J Moore, Alaric Colville, Neeraj Bhala, Tariq H Iqbal, Christopher Settle, Graziella Kontkowski, Ailsa L Hart, Peter M Hawkey, Simon D Goldenberg, Horace R T Williams

Gut Nov 2018, 67 (11) 1920-1941; DOI: 10.1136/gutjnl-2018-316818
Caecal ulceration in an asymptomatic man
Nan Wu, John Saul Freiman

Gut May 2017, 66 (5) 886; DOI: 10.1136/gutjnl-2016-312811

Main menu